Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) is advising publicly listed Evotec SE on the acquisition of Central Glass Germany GmbH from Japanese chemical manufacturing company Central Glass Co. Ltd. Central Glass Germany is an EU GMP certified contract developer and manufacturer (CDMO) of active pharmaceutical ingredients with a drug substance manufacturing facility in Halle […]
The post Freshfields advises Evotec on acquisition of Central Glass Germany appeared first on Legal Desire.